BACH: Biomarkers in Acute Heart Failure

Sponsor
Brahms AG (Industry)
Overall Status
Completed
CT.gov ID
NCT00537628
Collaborator
(none)
1,641
15
15
109.4
7.3

Study Details

Study Description

Brief Summary

Primary Objectives

  1. Mid Region pro Adrenomedullin (MR-proADM) is superior to BNP for the prognosis of heart failure (HF) patients and adds incremental value in predicting outcomes for patients presenting to the Emergency Department (ED) with shortness of breath.

  2. Mid Region pro A-Type Natriuretic Peptide (MR-proANP) is non-inferior to BNP for the diagnosis of HF in patients presenting to the ED with shortness of breath.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The diagnosis of heart failure is often very difficult. Clinical history is often vague, and physical examination findings suffer from lack of specificity and sensitivity. For example, symptoms like shortness of breath and edema are often present in patients without cardiac disease, while elevated jugular venous pressure can be difficult to visualize and auscultation of a third heart sound can be challenging to hear, especially in an emergency room setting.

    Although BNP levels can sometimes help clarify the clinical picture when patients present acutely with shortness of breath, patients both with and without heart failure may have BNP values that fall into a "gray zone", where the diagnosis is still very much in question. Also, there can be difficulties in interpreting BNP levels in patients with renal dysfunction, patients with a high body mass index, and patients of advanced age.

    Investigative tests in the emergency department such as the electrocardiogram or chest x-ray are also non-specific for diagnosing heart failure. Tests such as echocardiography, while accurate in the assessment of left ventricular dysfunction, are expensive and are not always available on an emergent basis; furthermore, the presence of heart failure with normal systolic function (a.k.a. diastolic dysfunction) can complicate the interpretation of echocardiograms. Additionally, just because a patient has systolic dysfunction on an urgent echocardiogram does not mean that their acute dyspnea is due to heart failure, and so the test itself may not accurately reflect the acute situation at hand.

    Another difficult diagnostic dilemma arises when a patient with a history of heart failure presents with signs that could also be consistent an acute respiratory illness such as pneumonia. Often, patients with background heart failure have elevated BNP levels at baseline. In this setting, chest radiographs can be especially difficult to interpret when one must distinguish between edema and infiltrates, or possibly both.

    For all of these reasons, there is a pressing need for additional tools to help us differentiate heart failure from other causes of dyspnea in our acutely short of breath patients, and to improve our ability to provide accurate prognostic information and sound therapeutic management to our heart failure patients.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1641 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Biomarkers in Acute Heart Failure: An International, Multi-Center Trial Evaluating the Prognostic and Diagnostic Utility of Biomarkers in Patients With Heart Failure Presenting With Shortness of Breath
    Study Start Date :
    Mar 1, 2007
    Actual Primary Completion Date :
    May 1, 2008
    Actual Study Completion Date :
    Jun 1, 2008

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Eighteen years of age or older.

      • The patients must be seen in the urgent care or emergency area with a chief complaint of shortness of breath not due to trauma.

      Exclusion Criteria:
      • Patient is unable to sign or understand the consent form.

      • Patient is on any dialysis.

      • Patient has trauma related shortness of breath (i.e. penetrating wounds, crush injury).

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University of California, San Diego San Diego California United States 92103
      2 Veterans Affairs Medical Center San Diego California United States 92161
      3 University of California, San Francisco San Francisco California United States 94110
      4 University of Maryland Baltimore Maryland United States 21201
      5 Henry Ford Health System Detroit Michigan United States 48202
      6 University of Minnesota Minneapolis Minnesota United States 55417
      7 The Cleveland Clinic Cleveland Ohio United States 44195
      8 Virgina Commonwealth University Richmond Virginia United States 23298
      9 Charite- Universitatsmedizin Berlin Berlin Germany 13353
      10 Athens University Hospital Attikon Athens Greece
      11 University La Sapienza Rome Italy 00189
      12 University of Otago Christchurch New Zealand
      13 Clinical Military Hospital Wroclaw Poland 50-891
      14 University Hospital Basel Basel Switzerland CH-4031
      15 University of Leicester Leicester United Kingdom LE2 7LX

      Sponsors and Collaborators

      • Brahms AG

      Investigators

      • Principal Investigator: Alan S Maisel, MD, Veterans Affairs Medical Center, San Diego and University of California, San Diego
      • Principal Investigator: Stefan D Anker, MD, PhD, Universitätsklinikum Charité, Charité - Campus Virchow
      • Study Chair: Frank Peacock, MD, The Cleveland Clinic

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00537628
      Other Study ID Numbers:
      • Brahms
      First Posted:
      Oct 1, 2007
      Last Update Posted:
      Aug 1, 2008
      Last Verified:
      Jul 1, 2008
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Aug 1, 2008